Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Fermér

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2003
Microwave-assisted high-speed PCRChristian Fermér, Peter Nilsson, Mats Larhed
Comparative Medicine|January 24, 2003
Development and use of a simple polymerase chain reaction assay to screen for Helicobacter spp. and H. hepaticus in intestinal and fecal samples from laboratory miceChristian Fermér, Anna V Lindberg, Ricardo E Feinstein
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Specificity rescue and affinity maturation of a low-affinity IgM antibody against pro-gastrin-releasing peptide using phage display and DNA shufflingChristian Fermér, Irma Andersson, Karin Nilsson, et al.
Journal of Immunological Methods|July 9, 2008
Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodiesMaria Lidqvist, Olle Nilsson, Jan Holmgren, et al.
Plos One|December 18, 2015
Podocalyxin as a Prognostic Marker in Gastric CancerAlli Laitinen, Camilla Böckelman, Jaana Hagström, et al.
The Journal of General Virology|October 21, 2011
Detection of human papillomavirus oncoprotein E7 in liquid-based cytologyMaria Lidqvist, Olle Nilsson, Jan Holmgren, et al.
BMC Cancer|July 10, 2014
A comparative study of two PODXL antibodies in 840 colorectal cancer patientsTuomas Kaprio, Jaana Hagström, Christian Fermér, et al.
BMC Cancer|July 10, 2014
Podocalyxin is a marker of poor prognosis in colorectal cancerTuomas Kaprio, Christian Fermér, Jaana Hagström, et al.
Plos One|June 9, 2015
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal AdenocarcinomaKapo Saukkonen, Jaana Hagström, Harri Mustonen, et al.
Anticancer Research|July 1, 2015
Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine TumorsJuha Jernman, Jaana Hagström, Hanna Mäenpää, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2003
Microwave-assisted high-speed PCRChristian Fermér, Peter Nilsson, Mats Larhed
Comparative Medicine|January 24, 2003
Development and use of a simple polymerase chain reaction assay to screen for Helicobacter spp. and H. hepaticus in intestinal and fecal samples from laboratory miceChristian Fermér, Anna V Lindberg, Ricardo E Feinstein
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Specificity rescue and affinity maturation of a low-affinity IgM antibody against pro-gastrin-releasing peptide using phage display and DNA shufflingChristian Fermér, Irma Andersson, Karin Nilsson, et al.
Journal of Immunological Methods|July 9, 2008
Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodiesMaria Lidqvist, Olle Nilsson, Jan Holmgren, et al.
Plos One|December 18, 2015
Podocalyxin as a Prognostic Marker in Gastric CancerAlli Laitinen, Camilla Böckelman, Jaana Hagström, et al.
The Journal of General Virology|October 21, 2011
Detection of human papillomavirus oncoprotein E7 in liquid-based cytologyMaria Lidqvist, Olle Nilsson, Jan Holmgren, et al.
BMC Cancer|July 10, 2014
A comparative study of two PODXL antibodies in 840 colorectal cancer patientsTuomas Kaprio, Jaana Hagström, Christian Fermér, et al.
BMC Cancer|July 10, 2014
Podocalyxin is a marker of poor prognosis in colorectal cancerTuomas Kaprio, Christian Fermér, Jaana Hagström, et al.
Plos One|June 9, 2015
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal AdenocarcinomaKapo Saukkonen, Jaana Hagström, Harri Mustonen, et al.
Anticancer Research|July 1, 2015
Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine TumorsJuha Jernman, Jaana Hagström, Hanna Mäenpää, et al.
Pageof 2